James Armitage

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Cyclophosphamide

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Bierman Philip J; Armitage James O
Looking back (and ahead) at salvage treatment for non-Hodgkin lymphoma.
Quddus Fahd; Armitage James O
Salvage therapy for Hodgkin's lymphoma.
Armitage James O
Cancer care--the relation between resources and outcome.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of James Armitage (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bierman Philip J; Armitage James O
Looking back (and ahead) at salvage treatment for non-Hodgkin lymphoma.
Oncology (Williston Park, N.Y.) 2009;23(7):619, 625.
2009: Quddus Fahd; Armitage James O
Salvage therapy for Hodgkin's lymphoma.
Cancer journal (Sudbury, Mass.) 2009;15(2):161-3.
2009: Armitage James O
Cancer care--the relation between resources and outcome.
Leukemia & lymphoma 2009;50(2):152-3.
2009: Armitage James O
Targeted therapy and hematological malignancy.
Targeted oncology 2009;4(1):1-2.
2008: Armitage James O
Hodgkin lymphoma and the impact of age.
Oncology (Williston Park, N.Y.) 2008;22(12):1379, 1385.
2008: Fu Kai; Weisenburger Dennis D; Choi William W L; Perry Kyle D; Smith Lynette M; Shi Xinlan; Hans Christine P; Greiner Timothy C; Bierman Philip J; Bociek R Gregory; Armitage James O; Chan Wing C; Vose Julie M
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4587-94.
2008: Armitage Joel D; Montero Carlos; Benner Alisha; Armitage James O; Bociek Gregory
Acute coronary syndromes complicating the first infusion of rituximab.
Clinical lymphoma & myeloma 2008;8(4):253-5.
2008: Armitage James O
Professionalism and cancer care.
Oncology (Williston Park, N.Y.) 2008;22(6):636-7.
2008: Nelson Marilu; Horsman Douglas E; Weisenburger Dennis D; Gascoyne Randy D; Dave Bhavana J; Loberiza Fausto R; Ludkovski Olga; Savage Kerry J; Armitage James O; Sanger Warren G
Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma.
British journal of haematology 2008;141(4):461-9.
2008: Armitage James O
Is lymphoma occurring in the elderly the same disease?
Leukemia & lymphoma 2008;49(1):14-6.
2008: Vose Julie M; Bierman Philip J; Loberiza Fausto R; Lynch James C; Bociek Gregory R; Weisenburger Dennis D; Armitage James O
Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1):36-42.
2007: Ganti Apar Kishor; Lee Stephanie J; Vose Julie M; Devetten Marcel P; Bociek R Gregory; Armitage James O; Bierman Philip J; Maness Lori J; Reed Elizabeth C; Loberiza Fausto R
Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(35):5643-8.
2007: Joshi Avadhut D; Hegde Ganapati V; Dickinson John D; Mittal Amit K; Lynch James C; Eudy James D; Armitage James O; Bierman Philip J; Bociek R Gregory; Devetten Marcel P; Vose Julie M; Joshi Shantaram S
ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5295-304.
2007: Devetten M; Armitage J O
Hematopoietic cell transplantation: progress and obstacles.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(9):1450-6.
2007: Lunning Matthew; Armitage James O
The curability of follicular lymphoma.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2007;37(1):31-5.
2007: Panwalkar Amit W; Armitage James O
T-cell/NK-cell lymphomas: a review.
Cancer letters 2007;253(1):1-13.
2007: Armitage James O
How I treat patients with diffuse large B-cell lymphoma.
Blood 2007;110(1):29-36.
2007: Wiestner Adrian; Tehrani Mahsa; Chiorazzi Michael; Wright George; Gibellini Federica; Nakayama Kazutaka; Liu Hui; Rosenwald Andreas; Muller-Hermelink H Konrad; Ott German; Chan Wing C; Greiner Timothy C; Weisenburger Dennis D; Vose Julie; Armitage James O; Gascoyne Randy D; Connors Joseph M; Campo Elias; Montserrat Emilio; Bosch Francesc; Smeland Erlend B; Kvaloy Stein; Holte Harald; Delabie Jan; Fisher Richard I; Grogan Thomas M; Miller Thomas P; Wilson Wyndham H; Jaffe Elaine S; Staudt Louis M
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
Blood 2007;109(11):4599-606.
2007: Vose Julie M; Bierman Philip J; Loberiza Fausto R; Bociek Robert G; Matso Daniel; Armitage James O
Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation.
Leukemia & lymphoma 2007;48(4):683-90.
2007: Joshi Avadhut D; Dickinson John D; Hegde Ganapati V; Sanger Warren G; Armitage James O; Bierman Philip J; Bociek Robert G; Devetten Marcel P; Vose Julie M; Joshi Shantaram S
Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.
Cancer genetics and cytogenetics 2007;172(2):120-6.
2006: Ganti A K; Weisenburger D D; Smith L M; Hans C P; Bociek R G; Bierman P J; Vose J M; Armitage J O
Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(6):920-7.
2006: Mikuls Ted R; Endo Justin O; Puumala Susan E; Aoun Patricia A; Black Natalie A; O'Dell James R; Stoner Julie A; Boilesen Eugene C; Bast Martin A; Bergman Debra A; Ristow Kay M; Ooi Melissa; Armitage James O; Habermann Thomas M
Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1597-602.
2006: Armitage James O; Bierman Philip J; Bociek R Gregory; Vose Julie M
Lymphoma 2006: classification and treatment.
Oncology (Williston Park, N.Y.) 2006;20(3):231-9; discussion 242, 244, 249.
2006: Greiner Timothy C; Dasgupta Chiranjib; Ho Vincent V; Weisenburger Dennis D; Smith Lynette M; Lynch James C; Vose Julie M; Fu Kai; Armitage James O; Braziel Rita M; Campo Elias; Delabie Jan; Gascoyne Randy D; Jaffe Elaine S; Muller-Hermelink Hans K; Ott German; Rosenwald Andreas; Staudt Louis M; Im Michael Y; Karaman Mazen W; Pike Brian L; Chan Wing C; Hacia Joseph G
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(7):2352-7.
2006: Iqbal Javeed; Neppalli Vishala T; Wright George; Dave Bhavana J; Horsman Douglas E; Rosenwald Andreas; Lynch James; Hans Christine P; Weisenburger Dennis D; Greiner Timothy C; Gascoyne Randy D; Campo Elias; Ott German; Müller-Hermelink H Konrad; Delabie Jan; Jaffe Elaine S; Grogan Thomas M; Connors Joseph M; Vose Julie M; Armitage James O; Staudt Louis M; Chan Wing C
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(6):961-8.
2005: Armitage James O
Staging non-Hodgkin lymphoma.
CA: a cancer journal for clinicians 2005;55(6):368-76.
2005: Hans Christine P; Weisenburger Dennis D; Greiner Timothy C; Chan Wing C; Aoun Patricia; Cochran Gregory T; Pan Zenggang; Smith Lynette M; Lynch James C; Bociek Robert Gregory; Bierman Philip J; Vose Julie M; Armitage James O
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(10):1377-84.
2005: Ganti Apar Kishor; Pipinos Iraklis; Culcea Eliad; Armitage James O; Tarantolo Stefano
Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome.
American journal of hematology 2005;79(3):206-10.
2005: Armitage James O
The treatment of patients with aggressive non-Hodgkin's lymphoma.
Oncology (Williston Park, N.Y.) 2005;19(4 Suppl 1):3-6.
2005: Pavletic Steven Z; Smith Lynette M; Bishop Michael R; Lynch James C; Tarantolo Stefano R; Vose Julie M; Bierman Philip J; Hadi Abdul; Armitage James O; Kessinger Anne
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
American journal of hematology 2005;78(4):265-74.
2005: Ganti A K; Bierman P J; Lynch J C; Bociek R G; Vose J M; Armitage J O
Hematopoietic stem cell transplantation in mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(4):618-24.
2005: Ganti Apar Kishor; Bociek R Gregory; Bierman Philip J; Enke Charles A; Vose Julie M; Armitage James O
Follicular lymphoma: expanding therapeutic options.
Oncology (Williston Park, N.Y.) 2005;19(2):213-28; discussion 228, 233-6, 239.
2005: Vose Julie M; Bierman Philip J; Enke Charles; Hankins Jordan; Bociek Gregory; Lynch James C; Armitage James O
Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):461-7.
2004: Nola Marin; Pavletic Steven Z; Weisenburger Dennis D; Smith Lynette M; Bast Martin A; Vose Julie M; Armitage James O
Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphoma.
American journal of hematology 2004;77(1):31-5.
2004: Huang James Z; Weisenburger Dennis D; Vose Julie M; Greiner Timothy C; Aoun Patricia; Chan Wing C; Lynch James C; Bierman Philip J; Armitage James O
Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group.
Leukemia & lymphoma 2004;45(8):1551-7.
2004: Iqbal Javeed; Sanger Warren G; Horsman Douglas E; Rosenwald Andreas; Pickering Diane L; Dave Bhavana; Dave Sandeep; Xiao Li; Cao Kajia; Zhu Quiming; Sherman Simon; Hans Christine P; Weisenburger Dennis D; Greiner Timothy C; Gascoyne Randy D; Ott German; Müller-Hermelink H Konrad; Delabie Jan; Braziel Rita M; Jaffe Elaine S; Campo Elias; Lynch James C; Connors Joseph M; Vose Julie M; Armitage James O; Grogan Thomas M; Staudt Louis M; Chan Wing C
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
The American journal of pathology 2004;165(1):159-66.
2004: Giles Francis J; Vose Julie M; Do Kim-Anh; Johnson Marcella M; Manshouri Taghi; Bociek Gregory; Bierman Philip J; O'Brien Susan M; Kantarjian Hagop M; Armitage James O; Albitar Maher
Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma.
Leukemia research 2004;28(6):595-604.
2004: Armitage James O; Tobinai Kensei; Hoelzer Dieter; Rummel Mathias J
Treatment of indolent non-Hodgkin's lymphoma with cladribine as single-agent therapy and in combination with mitoxantrone.
International journal of hematology 2004;79(4):311-21.
2004: Archuleta Travis D; Armitage James O
Advances in follicular lymphoma.
Seminars in oncology 2004;31(2 Suppl 4):66-71.
2004: Archuleta T D; Devetten M P; Armitage J O
Hematopoietic stem cell transplantation in hematologic malignancy.
Panminerva medica 2004;46(1):61-74.
2004: Vose Julie M; Rizzo Douglas J; Tao-Wu Jing; Armitage James O; Bashey Asad; Burns Linda J; Christiansen Neal Paul; Freytes Cesar O; Gale Robert Peter; Gibson John; Giralt Sergio A; Herzig Roger H; Lemaistre Charles F; McCarthy Philip L; Nimer Stephen D; Petersen Finn B; Schenkein David P; Wiernik Peter H; Wiley Joseph M; Loberiza Fausto R; Lazarus Hillard M; van Biesen Koen; Horowitz Mary M
Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(2):116-27.
2004: Hans Christine P; Weisenburger Dennis D; Greiner Timothy C; Gascoyne Randy D; Delabie Jan; Ott German; Müller-Hermelink H Konrad; Campo Elias; Braziel Rita M; Jaffe Elaine S; Pan Zenggang; Farinha Pedro; Smith Lynette M; Falini Brunangelo; Banham Alison H; Rosenwald Andreas; Staudt Louis M; Connors Joseph M; Armitage James O; Chan Wing C
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Blood 2004;103(1):275-82.
2003: Giles Francis J; Vose Julie M; Do Kim-Anh; Johnson Marcella M; Manshouri Taghi; Bociek Gregory; Bierman Philip J; O'Brien Susan M; Keating Michael J; Kantarjian Hagop M; Armitage James O; Albitar Maher
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease.
British journal of haematology 2003;123(5):850-7.
2003: Huang James Z; Weisenburger Dennis D; Vose Julie M; Greiner Timothy C; Aoun Patricia; Chan Wing C; Lynch James C; Bierman Philip J; Armitage James O;
Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group.
Leukemia & lymphoma 2003;44(11):1903-10.
2003: van Besien Koen; Loberiza Fausto R; Bajorunaite Ruta; Armitage James O; Bashey Asad; Burns Linda J; Freytes Cesar O; Gibson John; Horowitz Mary M; Inwards David J; Marks David I; Martino Rodrigo; Maziarz Richard T; Molina Arturo; Pavlovsky Santiago; Pecora Andrew L; Schouten Harry C; Shea Thomas C; Lazarus Hillard M; Rizzo J Douglas; Vose Julie M
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.
Blood 2003;102(10):3521-9.
2003: Pavletic Steven Z; Bociek R Gregory; Foran James M; Rubocki Ronald J; Kuszynski Charles A; Wisecarver James L; Hatcher Lori; Lucas David M; Byrd John C; Grever Michael R; Joshi Shantaram S; Hardiman Penny; Smith Lynette M; McGuire Timothy R; Bierman Philip J; Vose Julie M; Armitage James O; Talmadge James E
Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation.
Transplantation 2003;76(5):877-81.
2003: Armitage James O
The evolving role of autologous hematopoietic stem cell transplantation for the treatment of patients with lymphoma.
Current hematology reports 2003;2(5):363-5.
2003: Fang Nicole Y; Greiner Timothy C; Weisenburger Dennis D; Chan Wing C; Vose Julie M; Smith Lynette M; Armitage James O; Mayer R Aeryn; Pike Brian L; Collins Francis S; Hacia Joseph G
Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(9):5372-7.
2003: Levine John E; Harris Richard E; Loberiza Fausto R; Armitage James O; Vose Julie M; Van Besien Koen; Lazarus Hillard M; Horowitz Mary M; Bashey Asad; Bolwell Brian J; Burns Linda J; Cairo Mitchell S; Champlin Richard E; Freytes Cesar O; Gibson John; Goldstein Steve C; Laughlin Mary J; Lister John; Marks David I; Maziarz Richard T; Miller Alan M; Milone Gustavo A; Pavlovsky Santiago; Pecora Amdrew L; Rizzo J Douglas; Schiller Gary; Schouten Harry C; Zhang Mei Jie;
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.
Blood 2003;101(7):2476-82.
2003: Hans Christine P; Weisenburger Dennis D; Vose Julie M; Hock Lynette M; Lynch James C; Aoun Patricia; Greiner Timothy C; Chan Wing C; Bociek Robert G; Bierman Philip J; Armitage James O
A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival.
Blood 2003;101(6):2363-7.
2003: Joshi S S; Bishop M R; Lynch J C; Tarantolo S R; Abhyankar S; Bierman P J; Vose J M; Geller R B; McGuirk J; Foran J; Bociek R G; Hadi A; Day S D; Armitage J O; Kessinger A; Pavletic Z S
Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
Cytotherapy 2003;5(6):542-52.
2002: Papenfuss Jason S; Aoun Patricia; Bierman Philip J; Armitage James O
Subcutaneous panniculitis-like T-cell lymphoma: presentation of 2 cases and observations.
Clinical lymphoma 2002;3(3):175-80.
2002: Armitage James O
Overview of rational and individualized therapeutic strategies for non-Hodgkin's lymphomas.
Clinical lymphoma 2002;3 Suppl 1():S5-11.
2002: Bierman P J; Lynch J C; Bociek R G; Whalen V L; Kessinger A; Vose J M; Armitage J O
The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1370-7.
2002: Vose Julie M; Sharp Graham; Chan Wing C; Nichols Craig; Loh Kevin; Inwards David; Rifkin Robert; Bierman Philip J; Lynch James C; Weisenburger Dennis D; Kessinger Anne; Armitage James O
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(9):2344-52.
2002: Vose Julie M; Weisenburger Dennis D; Lynch James C; Bierman Philip J; Chan John C; Bast Martin; Aoun Patricia; Bociek Gregory; Greiner Timothy; Armitage James O;
CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience.
Leukemia & lymphoma 2002;43(4):799-804.
2002: Armitage James O
The role of mitoxantrone in non-Hodgkin's lymphoma.
Oncology (Williston Park, N.Y.) 2002;16(4):490-502, 507-8; discussion 511-2, 514.
2002: Huang James Z; Sanger Warren G; Greiner Timothy C; Staudt Louis M; Weisenburger Dennis D; Pickering Diane L; Lynch James C; Armitage James O; Warnke Roger A; Alizadeh Ash A; Lossos Izidore S; Levy Ronald; Chan Wing C
The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile.
Blood 2002;99(7):2285-90.
2002: Weekes Colin D; Vose Julie M; Lynch Jim C; Weisenburger Dennis D; Bierman Philip J; Greiner Timothy; Bociek Gregory; Enke Charles; Bast Martin; Chan Wing C; Armitage James O;
Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):1087-93.
2002: Diebold J; Anderson J R; Armitage J O; Connors J M; Maclennan K A; Müller-Hermelink H K; Nathwani B N; Ullrich F; Weisenburger D D
Diffuse large B-cell lymphoma: a clinicopathologic analysis of 444 cases classified according to the updated Kiel classification.
Leukemia & lymphoma 2002;43(1):97-104.
2002: Rüdiger T; Weisenburger D D; Anderson J R; Armitage J O; Diebold J; MacLennan K A; Nathwani B N; Ullrich F; Müller-Hermelink H K;
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(1):140-9.
2002: Dave Bhavana J; Nelson Marilu; Pickering Diane L; Chan Wing C; Greiner Timothy C; Weisenburger Dennis D; Armitage James O; Sanger Warren G
Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization.
Cancer genetics and cytogenetics 2002;132(2):125-32.
2001: Weisenburger D D; Anderson J R; Diebold J; Gascoyne R D; MacLennan K A; Müller-Hermelink H K; Nathwani B N; Ullrich F; Armitage J O
Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project.
American journal of hematology 2001;67(3):172-8.
2001: Lazarus H M; Loberiza F R; Zhang M J; Armitage J O; Ballen K K; Bashey A; Bolwell B J; Burns L J; Freytes C O; Gale R P; Gibson J; Herzig R H; LeMaistre C F; Marks D; Mason J; Miller A M; Milone G A; Pavlovsky S; Reece D E; Rizzo J D; van Besien K; Vose J M; Horowitz M M
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Bone marrow transplantation 2001;27(4):387-96.
2001: Vose J M; Zhang M J; Rowlings P A; Lazarus H M; Bolwell B J; Freytes C O; Pavlovsky S; Keating A; Yanes B; van Besien K; Armitage J O; Horowitz M M;
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):406-13.
2001: Vose J M; Bierman P J; Lynch J C; Atkinson K; Juttner C; Hanania C E; Bociek G; Armitage J O
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(12):680-7.
2000: Bishop M R; Tarantolo S R; Geller R B; Lynch J C; Bierman P J; Pavletic Z S; Vose J M; Kruse S; Dix S P; Morris M E; Armitage J O; Kessinger A
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation.
Blood 2000;96(1):80-5.
2000: Weisenburger D D; Vose J M; Greiner T C; Lynch J C; Chan W C; Bierman P J; Dave B J; Sanger W G; Armitage J O
Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group.
American journal of hematology 2000;64(3):190-6.
2000: Bishop M R; Tarantolo S R; Pavletic Z S; Lynch J C; Morris M E; Zacharias D; Armitage J O; Kessinger A
Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(11):2269-72.
2000: Pavletic Z S; Arrowsmith E R; Bierman P J; Goodman S A; Vose J M; Tarantolo S R; Stein R S; Bociek G; Greer J P; Wu C D; Kollath J P; Weisenburger D D; Kessinger A; Wolff S N; Armitage J O; Bishop M R
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia.
Bone marrow transplantation 2000;25(7):717-22.
2000: Armitage J O; Coiffier B
Activity of interferon-alpha in relapsed patients with diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(3):359-61.
2000: Weisenburger D D; Gascoyne R D; Bierman P J; Shenkier T; Horsman D E; Lynch J C; Chan W C; Greiner T C; Connors J M; Vose J M; Armitage J O; Sanger W G
Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma.
Leukemia & lymphoma 2000;36(5-6):513-23.
2000: Vose J M; Bierman P J; Weisenburger D D; Lynch J C; Bociek Y; Chan W C; Greiner T C; Armitage J O
Autologous hematopoietic stem cell transplantation for mantle cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(6):640-5.
1999: Rowlings P A; Williams S F; Antman K H; Fields K K; Fay J W; Reed E; Pelz C J; Klein J P; Sobocinski K A; Kennedy M J; Freytes C O; McCarthy P L; Herzig R H; Stadtmauer E A; Lazarus H M; Pecora A L; Bitran J D; Wolff S N; Gale R P; Armitage J O; Vaughan W P; Spitzer G; Horowitz M M
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.
JAMA : the journal of the American Medical Association 1999;282(14):1335-43.
1999: Nathwani B N; Anderson J R; Armitage J O; Cavalli F; Diebold J; Drachenberg M R; Harris N L; MacLennan K A; Müller-Hermelink H K; Ullrich F A; Weisenburger D D
Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2486-92.
1999: Arcaroli J J; Dave B J; Pickering D L; Hess M M; Armitage J O; Weisenburger D D; Sanger W G
Is a duplication of 14q32 a new recurrent chromosomal alteration in B-cell non-Hodgkin lymphoma?
Cancer genetics and cytogenetics 1999;113(1):19-24.
1999: Tezcan H; Vose J M; Bast M; Bierman P J; Kessinger A; Armitage J O
Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.
Leukemia & lymphoma 1999;34(3-4):273-85.
1999: Bociek R G; Armitage J O
Hodgkin's disease and non-Hodgkin's lymphoma.
Current opinion in hematology 1999;6(4):205-15.
1999: Dave B J; Hess M M; Pickering D L; Zaleski D H; Pfeifer A L; Weisenburger D D; Armitage J O; Sanger W G
Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1401-9.
1999: Cheson B D; Horning S J; Coiffier B; Shipp M A; Fisher R I; Connors J M; Lister T A; Vose J; Grillo-López A; Hagenbeek A; Cabanillas F; Klippensten D; Hiddemann W; Castellino R; Harris N L; Armitage J O; Carter W; Hoppe R; Canellos G P
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1244.
1999: Nathwani B N; Anderson J R; Armitage J O; Cavalli F; Diebold J; Drachenberg M R; Harris N L; MacLennan K A; Müller-Hermelink H K; Ullrich F A; Weisenburger D D
Clinical significance of follicular lymphoma with monocytoid B cells. Non-Hodgkin's Lymphoma Classification Project.
Human pathology 1999;30(3):263-8.
1999: Baker K S; Gordon B G; Gross T G; Abromowitch M A; Lyden E R; Lynch J C; Vose J M; Armitage J O; Coccia P F; Bierman P J
Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):825-31.
1999: Abou-Elella A A; Weisenburger D D; Vose J M; Kollath J P; Lynch J C; Bast M A; Bierman P J; Greiner T C; Chan W C; Armitage J O
Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):784-90.
1999: Lazarus H M; Rowlings P A; Zhang M J; Vose J M; Armitage J O; Bierman P J; Gajewski J L; Gale R P; Keating A; Klein J P; Miller C B; Phillips G L; Reece D E; Sobocinski K A; van Besien K; Horowitz M M
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):534-45.
1999: Shipp M A; Abeloff M D; Antman K H; Carroll G; Hagenbeek A; Loeffler M; Montserrat E; Radford J A; Salles G; Schmitz N; Symann M; Armitage J O; Philip T; Coiffier B
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):423-9.
1999: Shipp M A; Abeloff M D; Antman K H; Carroll G; Hagenbeek A; Loeffler M; Montserrat E; Radford J A; Salles G; Schmitz N; Symann M; Armitage J O; Coiffier B; Philip T
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(1):13-9.
1999: Dave B J; Pickering D L; Hess M M; Weisenburger D D; Armitage J O; Sanger W G
Deletion of cell division cycle 2-like 1 gene locus on 1p36 in non-Hodgkin lymphoma.
Cancer genetics and cytogenetics 1999;108(2):120-6.
1999: Alizadeh A; Eisen M; Davis R E; Ma C; Sabet H; Tran T; Powell J I; Yang L; Marti G E; Moore D T; Hudson J R; Chan W C; Greiner T; Weisenburger D; Armitage J O; Lossos I; Levy R; Botstein D; Brown P O; Staudt L M
The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes.
Cold Spring Harbor symposia on quantitative biology 1999;64():71-8.
1998: Armitage J O
Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor.
Blood 1998;92(12):4491-508.
1998: Armitage J O
Management of mantle cell lymphoma.
Oncology (Williston Park, N.Y.) 1998;12(10 Suppl 8):49-55.
1998: Pavletic Z S; Bierman P J; Vose J M; Bishop M R; Wu C D; Pierson J L; Kollath J P; Weisenburger D D; Kessinger A; Armitage J O
High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):1023-6.
1998: van Besien K; Sobocinski K A; Rowlings P A; Murphy S C; Armitage J O; Bishop M R; Chaekal O K; Gale R P; Klein J P; Lazarus H M; McCarthy P L; Raemaekers J M; Reiffers J; Phillips G L; Schattenberg A V; Verdonck L F; Vose J M; Horowitz M M
Allogeneic bone marrow transplantation for low-grade lymphoma.
Blood 1998;92(5):1832-6.
1998: Armitage J O; Weisenburger D D
New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2780-95.
1998: Anderson J R; Armitage J O; Weisenburger D D
Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(7):717-20.
1998: Vose J M; Bierman P J; Lynch J C; Weisenburger D D; Kessinger A; Chan W C; Greiner T C; Armitage J O
Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):844-9.
1998: Pavletic Z S; Joshi S S; Pirruccello S J; Tarantolo S R; Kollath J; Reed E C; Bierman P J; Vose J M; Warkentin P I; Gross T G; Nasrati K; Armitage J O; Kessinger A; Bishop M R
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies.
Bone marrow transplantation 1998;21(1):33-41.
1998: Armitage J O
Long-term toxicity of the treatment of Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 5():S133-6.
1998: Haire W D; Ruby E I; Stephens L C; Reed E; Tarantolo S R; Pavletic Z S; Bierman P J; Bishop M; Kessinger A; Vose J; Armitage J O
A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(3):142-50.
1998: Diebold J; Weisenburger D; MacLennan K A; Müller-Hermelink H K; Nathwani B N; Harris N L; Anderson J R; Roy P; Armitage J O
[Reproducibility and prognostic value of histopathological classifications of malignant lymphomas. Prolegomena for the 1st international classification proposed by WHO. Group of the non-Hodgkin's Malignant Lymphoma Classification Project]
Bulletin de l'Académie nationale de médecine 1998;182(7):1537-48; discussion 1548-9.
1997: Bishop M R; Jackson J D; Tarantolo S R; O'Kane-Murphy B; Iversen P L; Bayever E; Joshi S M; Sharp J G; Pierson J L; Warkentin P I; Armitage J O; Kessinger A
Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome.
Journal of hematotherapy 1997;6(5):441-6.
1997: Armitage J O
The development of bone marrow transplantation as a treatment for patients with lymphoma--twentieth Richard and Hinda Rosenthal Foundation Award Lecture.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(6):829-36.
1997: Mann S L; Joshi S S; Crouse D A; Armitage J O; Kessinger A; Weisenburger D D; Vaughan W P; Sharp J G
Increased hematopoietic progenitor cell maintenance in long-term bone marrow cultures containing minimal numbers of contaminating breast cancer cells.
Breast cancer research and treatment 1997;44(2):115-21.
1997: Antman K H; Rowlings P A; Vaughan W P; Pelz C J; Fay J W; Fields K K; Freytes C O; Gale R P; Hillner B E; Holland H K; Kennedy M J; Klein J P; Lazarus H M; McCarthy P L; Saez R; Spitzer G; Stadtmauer E A; Williams S F; Wolff S; Sobocinski K A; Armitage J O; Horowitz M M
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1870-9.
1997: Pavletic Z S; Bishop M R; Tarantolo S R; Martin-Algarra S; Bierman P J; Vose J M; Reed E C; Gross T G; Kollath J; Nasrati K; Jackson J D; Armitage J O; Kessinger A
Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1608-16.
1997: Bishop M R; Tarantolo S R; Jackson J D; Anderson J R; Schmit-Pokorny K; Zacharias D; Pavletic Z S; Pirruccello S J; Vose J M; Bierman P J; Warkentin P I; Armitage J O; Kessinger A
Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1601-7.
1997: Wszolek Z K; Steg R E; Armitage J O
Complex partial status epilepticus after bone marrow transplantation for non-Hodgkin's lymphoma.
Bone marrow transplantation 1997;19(6):637-8.
1997: Bierman P J; Vose J M; Anderson J R; Bishop M R; Kessinger A; Armitage J O
High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):445-50.
1996: Bishop M R; Jackson J D; O'Kane-Murphy B; Schmit-Pokorny K; Vose J M; Bierman P J; Warkentin P I; Armitage J O; Garrison L; Kessinger A
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2521-6.
1996: Vose J M; Bierman P J; Anderson J R; Harrison K A; Dalrymple G V; Byar K; Kessinger A; Armitage J O
Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2473-9.
1996: Vose J M; Bierman P J; Ruby E; Reed E C; Bishop M R; Tarantolo S; Kessinger A; Armitage J O
Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
Bone marrow transplantation 1996;17(6):951-6.
1996: Weisenburger D D; Armitage J O
Mantle cell lymphoma-- an entity comes of age.
Blood 1996;87(11):4483-94.
1996: Bishop M R; Iversen P L; Bayever E; Sharp J G; Greiner T C; Copple B L; Ruddon R; Zon G; Spinolo J; Arneson M; Armitage J O; Kessinger A
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1320-6.
1996: Bierman P J; Anderson J R; Freeman M B; Vose J M; Kessinger A; Bishop M R; Armitage J O
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(2):151-6.
1996: Gajewski J L; Phillips G L; Sobocinski K A; Armitage J O; Gale R P; Champlin R E; Herzig R H; Hurd D D; Jagannath S; Klein J P; Lazarus H M; McCarthy P L; Pavlovsky S; Peterson F B; Rowlings P A; Russell J A; Silver S M; Vose J M; Wiernik P H; Bortin M M; Horowitz M M
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):572-8.
1996: Vose J M; Anderson J E; Bierman P J; Appelbaum F R; Anderson J R; Garrison L; Lebsack M E; Armitage J O
Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):520-6.
1996: Sharp J G; Kessinger A; Mann S; Crouse D A; Armitage J O; Bierman P; Weisenburger D D
Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):214-9.
1996: Pavletic Z S; Bishop M R; Bierman P J; Armitage J O
Bone marrow transplantation in chronic lymphocytic leukemia and lymphomas.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1996;50(3-4):118-24.
1995: Martin-Algarra S; Bishop M R; Tarantolo S; Cowles M K; Reed E; Anderson J R; Vose J M; Bierman P; Armitage J O; Kessinger A
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Experimental hematology 1995;23(14):1503-8.
1995: Grierson H L; Wooldridge T N; Hess M; Ratashak A; Wooldridge L; Fordyce-Boyer R; Bast M; Armitage J O; Weisenburger D D; Sanger W G
Proliferative fraction and DNA content are lower in B-cell non-Hodgkin's lymphomas with the t(14;18).
Leukemia & lymphoma 1995;19(3-4):253-7.
1995: Kessinger A; Bishop M R; Jackson J D; O'Kane-Murphy B; Vose J M; Bierman P J; Reed E C; Warkentin P I; Armitage J O; Sharp J G
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies.
Experimental hematology 1995;23(7):609-12.
1995: Martin A R; Weisenburger D D; Chan W C; Ruby E I; Anderson J R; Vose J M; Bierman P J; Bast M A; Daley D T; Armitage J O
Prognostic value of cellular proliferation and histologic grade in follicular lymphoma.
Blood 1995;85(12):3671-8.
1995: Yan Y; Chan W C; Weisenburger D D; Anderson J R; Bast M A; Vose J M; Bierman P J; Armitage J O
Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1336-42.
1995: Vaughan W P; Kris E; Vose J; Bierman P J; Gwilt P; Armitage J O
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1089-95.
1995: Grierson H L; Wooldridge T N; Hess M; Wooldridge L; Ratashak A; Bast M; Armitage J O; Weisenburger D D; Sanger W G
Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics.
Cancer genetics and cytogenetics 1995;80(2):124-8.
1995: Kessinger A; Bishop M R; Anderson J R; Armitage J O; Bierman P J; Reed E C; Tarantolo S; Tempero M A; Vose J M; Warkentin P I
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization.
Journal of hematotherapy 1995;4(2):81-4.
1995: Vose J M; Armitage J O
Clinical applications of hematopoietic growth factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(4):1023-35.
1995: Stewart D A; Vose J M; Weisenburger D D; Anderson J R; Ruby E I; Bast M A; Bierman P J; Kessinger A; Armitage J O
The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(3):263-6.
1995: Armitage J O; Bierman P J; Vose J M; Bishop M R; Kessinger M A
Autologous bone marrow transplantation for Hodgkin's disease.
Journal of hematotherapy 1995;4(1):61-2.
1995: Passweg J R; Rowlings P A; Armitage J O; Gale R P; Pelz C J; Sobocinski K A; Klein J P; Zhang M J; Horowitz M M
Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America.
Clinical transplants 1995;():117-27.
1994: Tezcan A Z; Tezcan H; Gastineau D A; Armitage J O; Haire W D
Heparin-induced thrombocytopenia after bone marrow transplantation: report of two cases.
Bone marrow transplantation 1994;14(3):487-90.
1994: Armitage J O; Vose J M; Bierman P J; Bishop M R
Salvage therapy for patients with lymphoma.
Seminars in oncology 1994;21(4 Suppl 7):82-5.
1994: Nashelsky M B; Hess M M; Weisenburger D D; Pierson J L; Bast M A; Armitage J O; Sanger W G
Cytogenetic abnormalities in B-immunoblastic lymphoma.
Leukemia & lymphoma 1994;14(5-6):415-20.
1994: Gordon B G; Weisenburger D D; Sanger W G; Armitage J O; Coccia P F
Peripheral T-cell lymphoma in children and adolescents: role of bone marrow transplantation.
Leukemia & lymphoma 1994;14(1-2):1-10.
1994: Vose J M; Anderson J R; Bierman P J; Bast M; Weisenburger D; Chan W C; Bishop M R; Armitage J O
Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
Seminars in hematology 1994;31(2 Suppl 3):4-8.
1994: Bishop M R; Anderson J R; Jackson J D; Bierman P J; Reed E C; Vose J M; Armitage J O; Warkentin P I; Kessinger A
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft.
Blood 1994;83(2):610-6.
1994: Armitage J O
Early bone marrow transplantation in Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():161-3.
1994: Sobocinski K A; Horowitz M M; Rowlings P A; Zhang M J; Nugent M L; Passweg J R; Armitage J O; Gale R P; Bortin M M
Bone marrow transplantation--1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry.
Journal of hematotherapy 1994;3(2):95-102.
1994: Rowlings P A; Passweg J R; Armitage J O; Gale R P; Sobocinski K A; Klein J P; Zhang M J; Horowitz M M
Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North America.
Clinical transplants 1994;():87-98.
1993: Bierman P J; Bagin R G; Jagannath S; Vose J M; Spitzer G; Kessinger A; Dicke K A; Armitage J O
High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(9):767-73.
1993: Armitage J O
Bone marrow transplantation for indolent lymphomas.
Seminars in oncology 1993;20(5 Suppl 5):136-42.
1993: Vose J M; Anderson J R; Kessinger A; Bierman P J; Coccia P; Reed E C; Gordon B; Armitage J O
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):1846-51.
1993: Bierman P J; Armitage J O
Bone marrow transplantation at the University of Nebraska Medical Center.
The Nebraska medical journal 1993;78(8):272-7.
1993: Vose J M; Armitage J O; Kessinger A
High-dose chemotherapy and autologous transplant with peripheral-blood stem cells.
Oncology (Williston Park, N.Y.) 1993;7(8):23-9; discussion 29-30, 33-4.
1993: Vose J M; Reed E C; Pippert G C; Anderson J R; Bierman P J; Kessinger A; Spinolo J; Armitage J O
Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1306-10.
1993: Bierman P J; Armitage J O
Role of autotransplantation in Hodgkin's disease.
Hematology/oncology clinics of North America 1993;7(3):591-611.
1993: Vose J M; Armitage J O
Role of autologous bone marrow transplantation in non-Hodgkin's lymphoma.
Hematology/oncology clinics of North America 1993;7(3):577-90.
1993: Nakamine H; Bagin R G; Vose J M; Bast M A; Bierman P J; Armitage J O; Weisenburger D D
Prognostic significance of clinical and pathologic features in diffuse large B-cell lymphoma.
Cancer 1993;71(10):3130-7.
1993: Nakamine H; Masih A S; Chan W C; Sanger W G; Armitage J O; Weisenburger D D
Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
Leukemia & lymphoma 1993;10(1-2):79-88.
1993: Bierman P J; Vose J M; Leichner P K; Quadri S M; Armitage J O; Klein J L; Abrams R A; Dicke K A; Vriesendorp H M
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):698-703.
1993: Iwen P C; Reed E C; Armitage J O; Bierman P J; Kessinger A; Vose J M; Arneson M A; Winfield B A; Woods G L
Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1993;14(3):131-9.
1993: Anderson J R; Vose J M; Bierman P J; Weisenberger D D; Sanger W G; Pierson J; Bast M; Armitage J O
Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):218-24.
1993: Gordon B G; Weisenburger D D; Warkentin P I; Anderson J; Sanger W G; Bast M; Gnarra D; Vose J M; Bierman P J; Armitage J O
Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients.
Cancer 1993;71(1):257-63.
1993: Vose J M; Armitage J O
What is the role of third generation regimens for initial therapy of non-Hodgkin's lymphomas?
Leukemia & lymphoma 1993;10 Suppl():61-4.
1993: Bishop M R; Bierman P J; Vose J M; Armitage J O
The role of high-dose therapy with hematopoietic stem cell rescue in low-grade non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4 Suppl 1():1-6.
1993: Kessinger A; Vose J M; Bierman P J; Bishop M; Armitage J O
Peripheral stem cell transplantation in non-Hodgkin's lymphoma patients.
Journal of hematotherapy 1993;2(3):361-2.
1993: Rowlings P A; Horowitz M M; Armitage J O; Gale R P; Sobocinski K A; Zhang M J; Bortin M M
Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry.
Clinical transplants 1993;():101-8.
1992: Gordon B G; Warkentin P I; Weisenburger D D; Vose J M; Sanger W G; Strandjord S E; Anderson J R; Verdirame J D; Bierman P J; Armitage J O
Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents.
Blood 1992;80(11):2938-42.
1992: Armitage J O
Myeloablative regimens in peripheral stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 4():88-9.
1992: Armitage J O
Chemotherapy for non-Hodgkin's lymphoma.
Current opinion in oncology 1992;4(5):840-6.
1992: Speaks S L; Sanger W G; Masih A S; Harrington D S; Hess M; Armitage J O
Recurrent abnormalities of chromosome bands 10q23-25 in non-Hodgkin's lymphoma.
Genes, chromosomes & cancer 1992;5(3):239-43.
1992: Armitage J O
The use of granulocyte-macrophage colony-stimulating factor in bone marrow transplantation.
Seminars in hematology 1992;29(4 Suppl 3):14-8.
1992: Vose J M; Bierman P J; Anderson J R; Kessinger A; Pierson J; Nelson J; Frappier B; Schmit-Pokorny K; Weisenburger D D; Armitage J O
Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up.
Blood 1992;80(8):2142-8.
1992: Armitage J O
Autologous bone marrow transplantation for Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():95-6.
1992: Sisson J H; Thompson A B; Anderson J R; Robbins R A; Spurzem J R; Spence P R; Reed E C; Armitage J O; Vose J M; Arneson M A
Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin disease.
The American review of respiratory disease 1992;146(2):439-43.
1992: Vaughan W P; Bierman P J; Reed E C; Glenn L D; Kessinger A; Armitage J O
High-dose hydroxyurea in autologous bone marrow transplantation: a promising "new" agent.
Seminars in oncology 1992;19(3 Suppl 9):110-5.
1992: Nakamine H; Masih A S; Sanger W G; Wickert R S; Mitchell D W; Armitage J O; Weisenburger D D
Richter's syndrome with different immunoglobulin light chain types. Molecular and cytogenetic features indicate a common clonal origin.
American journal of clinical pathology 1992;97(5):656-63.
1992: Sharp J G; Joshi S S; Armitage J O; Bierman P; Coccia P F; Harrington D S; Kessinger A; Crouse D A; Mann S L; Weisenburger D D
Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique.
Blood 1992;79(4):1074-80.
1992: Vose J M; Kennedy B C; Bierman P J; Kessinger A; Armitage J O
Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies.
Cancer 1992;69(3):784-9.
1992: Masih A S; Weisenburger D D; Vose J M; Bast M A; Armitage J O
Histologic grade does not predict prognosis in optimally treated, advanced-stage nodular sclerosing Hodgkin's disease.
Cancer 1992;69(1):228-32.
1992: Armitage J O
Autologous bone marrow transplantation for patients with aggressive non-Hodgkin's lymphoma.
Bone marrow transplantation 1992;10 Suppl 1():62-3.
1992: Armitage J O
Should bone marrow transplantation be included in the primary therapy of patients with aggressive lymphoma?
Leukemia & lymphoma 1992;7 Suppl():1-2.
1991: Armitage J O; Bierman P J; Vose J M; Anderson J R; Weisenburger D D; Kessinger A; Reed E C; Vaughan W P; Coccia P F; Purtilo D T
Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.
The American journal of medicine 1991;91(6):605-11.
1991: Bashir R M; Bierman P J; Vose J M; Weisenburger D D; Armitage J O
Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma.
American journal of clinical oncology 1991;14(6):478-82.
1991: Lobo F; Kessinger A; Landmark J D; Smith D M; Weisenburger D D; Wigton R S; Armitage J O
Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy.
Bone marrow transplantation 1991;8(5):389-92.
1991: Kessinger A; Vose J M; Bierman P J; Armitage J O
High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging.
Experimental hematology 1991;19(10):1013-6.
1991: Vose J M; Bierman P J; Weisenburger D D; Armitage J O
The therapy of non-Hodgkin's lymphomas. Introduction and overview.
Hematology/oncology clinics of North America 1991;5(5):845-52.
1991: Nakamine H; Masih A S; Strobach R S; Duggan M J; Bast M A; Armitage J O; Weisenburger D D
Immunoblastic lymphoma with abundant clear cytoplasm. A comparative study of B- and T-cell types.
American journal of clinical pathology 1991;96(2):177-83.
1991: Conlan M G; Haire W D; Kessinger A; Armitage J O
Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma presenting for autologous stem cell transplantation.
Bone marrow transplantation 1991;7(6):475-9.
1991: Kessinger A; Bierman P J; Vose J M; Armitage J O
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease.
Blood 1991;77(11):2322-5.
1991: Conlan M G; Armitage J O; Bast M; Weisenburger D D
Clinical significance of hematologic parameters in non-Hodgkin's lymphoma at diagnosis.
Cancer 1991;67(5):1389-95.
1991: Conlan M G; Haire W D; Lieberman R P; Lund G; Kessinger A; Armitage J O
Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation.
Bone marrow transplantation 1991;7(3):235-40.
1991: Vose J M; Armitage J O
The present status of therapy for patients with aggressive non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():171-6.
1991: Vose J M; Armitage J O
Diffuse "histiocytic" lymphoma.
Seminars in oncology 1991;18(1):50-60.
1991: Vose J M; Bierman P J; Kessinger A; Coccia P F; Anderson J; Oldham F B; Epstein C; Armitage J O
The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
Bone marrow transplantation 1991;7(2):139-43.
1991: Armitage J O
The place of third-generation regimens in the treatment of adult aggressive non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 1():37-41.
1991: Haire W D; Lieberman R P; Lund G B; Edney J A; Kessinger A; Armitage J O
Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: prospective comparison of Hickman and Groshong catheters.
Bone marrow transplantation 1991;7(1):57-9.
1991: Bierman P J; Vose J M; Armitage J O
Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: issues and controversies.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5 Suppl 1():58-62.
1990: Vose J M; Bierman P J; Armitage J O
Hodgkin's disease: the role of bone marrow transplantation.
Seminars in oncology 1990;17(6):749-57.
1990: Schouten H C; Maragos D; Vose J; Armitage J O
Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation.
Bone marrow transplantation 1990;6(5):333-5.
1990: Perry D A; Bast M A; Armitage J O; Weisenburger D D
Diffuse intermediate lymphocytic lymphoma. A clinicopathologic study and comparison with small lymphocytic lymphoma and diffuse small cleaved cell lymphoma.
Cancer 1990;66(9):1995-2000.
1990: Armitage J O
Bone marrow transplantation in the treatment of lymphoma.
Current opinion in oncology 1990;2(5):843-8.
1990: Haire W D; Lieberman R P; Edney J; Vaughan W P; Kessinger A; Armitage J O; Goldsmith J C
Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation.
Cancer 1990;66(5):900-8.
1990: Grierson H L; Wooldridge T N; Purtilo D T; Pierson J; Bast M; Wooldridge L; Armitage J O; Weisenburger D D
Low proliferative activity is associated with a favorable prognosis in peripheral T-cell lymphoma.
Cancer research 1990;50(16):4845-8.
1990: Duggan M J; Weisenburger D D; Ye Y L; Bast M A; Pierson J L; Linder J; Armitage J O
Mantle zone lymphoma. A clinicopathologic study of 22 cases.
Cancer 1990;66(3):522-9.
1990: Armitage J O
Minimal residual disease: lessons to be learned from malignant lymphoma.
Bone marrow transplantation 1990;6 Suppl 1():73-5.
1990: Haire W D; Lieberman R P; Lund G B; Wieczorek B M; Armitage J O; Kessinger A
Translumbar inferior vena cava catheters: safety and efficacy in peripheral blood stem cell transplantation.
Transfusion 1990;30(6):511-5.
1990: Vose J M; Peterson C; Bierman P J; Weisenburger D D; Linder J; Harrington D; Vaughan W P; Kessinger A; Armitage J O
Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas.
Blood 1990;76(2):424-31.
1990: Conlan M G; Bast M; Armitage J O; Weisenburger D D
Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(7):1163-72.
1990: Kessinger A; Nademanee A; Forman S J; Armitage J O
Autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
Hematology/oncology clinics of North America 1990;4(3):577-87.
1990: Schouten H C; Sanger W G; Weisenburger D D; Anderson J; Armitage J O
Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group.
Blood 1990;75(9):1841-7.
1990: Lund G B; Lieberman R P; Haire W D; Martin V A; Kessinger A; Armitage J O
Translumbar inferior vena cava catheters for long-term venous access.
Radiology 1990;174(1):31-5.
1990: Haire W D; Lieberman R P; Lund G B; Wieczorek B M; Armitage J O; Kessinger A
Translumbar inferior vena cava catheters: experience with 58 catheters in peripheral stem cell collection and transplantation.
Transfusion science 1990;11(2):195-200.
1990: Schouten H C; Kessinger A; Smith D M; Landmark J D; Wigton R S; Weisenburger D D; Armitage J O
Counterflow centrifugation apheresis for the collection of autologous peripheral blood stem cells from patients with malignancies: a comparison with a standard centrifugation apheresis procedure.
Journal of clinical apheresis 1990;5(3):140-4.
1989: Armitage J O; Vose J M; Linder J; Weisenburger D; Harrington D; Casey J; Bierman P; Sorensen S; Hutchins M; Moravec D F
Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(12):1783-90.
1989: Robbins R A; Linder J; Stahl M G; Thompson A B; Haire W; Kessinger A; Armitage J O; Arneson M; Woods G; Vaughan W P
Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients.
The American journal of medicine 1989;87(5):511-8.
1989: Schouten H C; Bierman P J; Vaughan W P; Kessinger A; Vose J M; Weisenburger D D; Armitage J O
Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation.
Blood 1989;74(7):2579-84.
1989: Kessinger A; Smith D M; Strandjord S E; Landmark J D; Dooley D C; Law P; Coccia P F; Warkentin P I; Weisenburger D D; Armitage J O
Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia.
Bone marrow transplantation 1989;4(6):643-6.
1989: Harrington D S; Braddock S W; Blocher K S; Weisenburger D D; Sanger W; Armitage J O
Lymphomatoid papulosis and progression to T cell lymphoma: an immunophenotypic and genotypic analysis.
Journal of the American Academy of Dermatology 1989;21(5 Pt 1):951-7.
1989: Vose J M; Armitage J O; Bierman P J; Weisenburger D D; Hutchins M; Dowling M D; Moravec D F; Sorensen S; Okerbloom J; Bascom G
Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation.
The American journal of medicine 1989;87(3):285-8.
1989: Kessinger A; Armitage J O; Smith D M; Landmark J D; Bierman P J; Weisenburger D D
High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma.
Blood 1989;74(4):1260-5.
1989: Schouten H C; Sanger W G; Duggan M; Weisenburger D D; MacLennan K A; Armitage J O
Chromosomal abnormalities in Hodgkin's disease.
Blood 1989;73(8):2149-54.
1989: Armitage J O
Bone marrow transplantation in the treatment of patients with lymphoma.
Blood 1989;73(7):1749-58.
1989: Armitage J O; Gale R P
Bone marrow autotransplantation.
The American journal of medicine 1989;86(2):203-6.
1989: Armitage J O; Greer J P; Levine A M; Weisenburger D D; Formenti S C; Bast M; Conley S; Pierson J; Linder J; Cousar J B
Peripheral T-cell lymphoma.
Cancer 1989;63(1):158-63.
1989: Schouten H C; Armitage J O; Klassen L W; Vaughan W P; Bierman P J; Weisenburger D; Kessinger A
Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.
Bone marrow transplantation 1989;4(1):119-21.
1988: Vose J M; Armitage J O; Weisenburger D D; Bierman P J; Sorensen S; Hutchins M; Moravec D F; Howe D; Dowling M D; Mailliard J
The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(12):1838-44.
1988: Wooldridge T N; Grierson H L; Weisenburger D D; Armitage J O; Sanger W G; Collins M M; Pierson J L; Pauza M E; Fordyce R; Purtilo D T
Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.
Cancer research 1988;48(22):6608-13.
1988: Vose J M; Armitage J O; Duggan M; Braddock S W
Pyoderma gangrenosum or cutaneous lymphoma: a difficult clinical diagnosis.
Cutis; cutaneous medicine for the practitioner 1988;42(4):335-7.
1988: Glenn L D; Armitage J O; Goldsmith J C; Sorensen S; Howe D; Weisenberger D D
Pulmonary emboli in patients receiving chemotherapy for non-Hodgkin's lymphoma.
Chest 1988;94(3):589-94.
1988: Armitage J O; Cheson B D
Interpretation of clinical trials in diffuse large-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(8):1335-47.
1988: Armitage J O; Sanger W G; Weisenburger D D; Harrington D S; Linder J; Bierman P J; Vose J M; Purtilo D T
Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21).
Journal of the National Cancer Institute 1988;80(8):576-80.
1988: Harrington D S; Patil K; Lai P K; Yasuda N N; Armitage J O; Ip S H; Weisenburger D D; Linder J; Purtilo D T
Soluble interleukin 2 receptors in patients with malignant lymphoma.
Archives of pathology & laboratory medicine 1988;112(6):597-601.
1988: Kessinger A; Armitage J O; Landmark J D; Smith D M; Weisenburger D D
Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy.
Blood 1988;71(3):723-7.
1987: Sanger W G; Armitage J O; Bridge J; Weisenburger D D; Fordyce R; Purtilo D T
Initial and subsequent cytogenetic studies in malignant lymphoma.
Cancer 1987;60(12):3014-9.
1987: Kessinger A; Armitage J O; Klassen L W; Landmark J D; Hayes J M; Larsen A E; Purtilo D T
Graft versus host disease following transfusion of normal blood products to patients with malignancies.
Journal of surgical oncology 1987;36(3):206-9.
1987: Linder J; Vaughan W P; Armitage J O; Ghafouri M A; Hurkman D; Mroczek E C; Miller N G; Rennard S I
Cytopathology of opportunistic infection in bronchoalveolar lavage.
American journal of clinical pathology 1987;88(4):421-8.
1987: Harrington D S; Ye Y L; Weisenburger D D; Armitage J O; Pierson J; Bast M; Purtilo D T
Malignant lymphoma in Nebraska and Guangzhou, China: a comparative study.
Human pathology 1987;18(9):924-8.
1987: Smith D M; Weisenburger D D; Bierman P; Kessinger A; Vaughan W P; Armitage J O
Acute renal failure associated with autologous bone marrow transplantation.
Bone marrow transplantation 1987;2(2):195-201.
1987: Speaks S L; Sanger W G; Linder J; Johnson D R; Armitage J O; Weisenburger D; Purtilo D
Chromosomal abnormalities in indolent lymphoma.
Cancer genetics and cytogenetics 1987;27(2):335-44.
1987: Kessinger A; Armitage J O
Harvesting marrow for autologous transplantation from patients with malignancies.
Bone marrow transplantation 1987;2(1):15-8.
1987: Vaughan W P; Weisenburger D D; Sanger W; Gale R P; Armitage J O
Early leukemic recurrence of non-Hodgkin lymphoma after high-dose anti-neoplastic therapy with autologous marrow rescue.
Bone marrow transplantation 1987;1(4):373-8.
1987: Joshi S S; Kessinger A; Mann S L; Stevenson M; Weisenburger D D; Vaughan W P; Armitage J O; Sharp J G
Detection of malignant cells in histologically normal bone marrow using culture techniques.
Bone marrow transplantation 1987;1(3):303-10.
1987: Vago J F; Weisenburger D D; Armitage J O
Do pathologic features predict prognosis in diffuse large B-cell lymphoma?
Hematologic pathology 1987;1(4):217-25.
1986: Armitage J O; Weisenburger D D; Hutchins M; Moravec D F; Dowling M; Sorensen S; Mailliard J; Okerbloom J; Johnson P S; Howe D
Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(2):160-4.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

James Armitage

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of James Armitage (preview)

All Publications